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Biological systems usually respond differently to enantiomers of a chiral molecule due to the
inherent chirality of the active receptor sites of enzymes in nature. Therefore, it highly desirable to
obtain molecules in enantiomerically pure form to achieve, for instance, interesting pharmacological
responses. For the synthesis of enantiomerically pure compounds, the chemist either can synthesize a
racemic mixture and then resolve it into their enantiomers or, much more efficiently, develop a synthesis
able to produce the desired compounds asymmetrically. Thus, asymmetric synthesis is an area of
research which experiences continuous developments, from the direct modification of chiral molecules
to the use of catalyzed reactions using chiral metal complexes or chiral metal-free organocatalysts.
This Special Issue collects research articles showing significant examples of recent developments in the
use of the existing different methodologies for the asymmetric synthesis of compounds of interest.
The use of an easily available initial enantiomerically pure compound as a template able to control
the stereoselectivity of the reaction when preparing interesting enantiopure products is illustrated by
Moriyama et al. [1]. Thus, (R)-glycidol is used as starting material for the preparation of the four chiral
diastereomers of pestalotin, which naturally is a gibberellin synergist, using a straightforward and
divergent manner based on the use of diastereoselective aldol and hetero-Diels–Alder reactions, as well
as Mitsunobu inversions. Han et al. show a diastereoselective process specifically developed for the
large-scale preparation of (S)-2-amino-4,4,4-trifluorobutanoic acid, a bioisostere of leucine moiety in
drug design [2]. In this case, a chiral auxiliary forms a nickel(II) complex with a glycine Schiff base and
is diastereoselectively alkylated with 2,2,2-trifluoroethyl iodide; the resulting complex is disassembled
to give the recyclable chiral auxiliary and the fluorinated amino acid in a multigram scale.
The use of catalysts is nowadays the most frequently used procedure when asymmetric reactions
are intended, as a small amount of a chiral species produces large quantities of an optically active
compound from a precursor. Metal complexes bearing chiral ligands have been the most employed
catalytic species in asymmetric transformations, and this Special Issue includes interesting examples.
Thus, the article by Claros et al. shows the use of a family of enantiopure ruthenium complexes
bearing phosphonite of phosphinite ligands in the catalytic asymmetric transfer hydrogenation of aryl
ketones with isopropyl alcohol as a hydrogen source, obtaining in some cases high conversions and
enantioselectivities of the corresponding benzyl alcohols [3]. Another example of the use of chiral
metal complexes as catalysts in asymmetric synthesis is shown by Liu et al. [4]. In this case, a chiral
nickel-aminophenol sulfonamide complex is employed as a catalyst for the asymmetric Henry reaction
between 2-acylpyridine N-oxide-including ketones with nitromethane; the reaction is a challenge as
N-oxides generally act as competitive catalyst inhibitors or displace the ligands.
In the last years, the use of organocatalysis in asymmetric synthesis has experienced growing
interest due to some advantages compared to the use of metal complexes as catalysts, such as their usual
higher stability, possible recyclability or lower ecological footprint due to the metal-free character of
these purely organic catalysts. Thus, the use of these organocatalysts is also represented in this Special
Issue, as is the case of the article by Manaprasertsak et al. which presents an efficient and economic
preparation of different C2-symmetrical 3,3′-diaryl substituted tetranaphthobisazepinium bromides;
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such compounds have shown wide application as highly efficient chiral phase-transfer catalysts [5].
The obtained catalysts are employed in the asymmetric substitution of a glycine-derived Schiff base
under phase-transfer conditions leading to enantioenriched amino acid derivatives. Another example
of the use of asymmetric organocatalysis is shown in the article by Torregrosa-Chinillach et al. where
a chiral primary amine-salicylamide is used as an organocatalyst for the enantioselective conjugate
addition of α,α-disubstituted aldehydes to maleimides and nitroalkenes, using deep eutectic solvents
as reaction media, with catalyst and solvent being recovered and reused [6]. These neoteric solvents
are growing in popularity due to their environmental advantages, such as low toxicity, low volatility,
and low price.
This Special Issue shows that the search for new methodologies suitable for achieving asymmetric
synthesis remains quite active, as still more efficient stereoselective methodologies need to be developed.
Asymmetric synthesis will continue to be a fast-moving research area in the coming years.
Conflicts of Interest: The author declares no conflict of interest.
References
1. Moriyama, M.; Nakata, K.; Fujiwara, T.; Tanabe, Y. Divergent Asymmetric Total Synthesis of All Four
Pestalotin Diastereomers from (R)-Glycidol. Molecules 2020, 25, 394. [CrossRef] [PubMed]
2. Han, J.; Takeda, R.; Liu, X.; Konno, H.; Abe, H.; Hiramatsu, T.; Moriwaki, H.; Soloshonok, V.A. Preparative
Method for Asymmetric Synthesis of (S)-2-Amino-4,4,4-Trifluorobutanoic Acid. Molecules 2019, 24, 4521.
[CrossRef] [PubMed]
3. Claros, M.; de Julián, E.; Díez, J.; Lastra, E.; Gamasa, P. Asymmetric Transfer Hydrogenation of Arylketones
Catalyzed by Enantiopure Ruthenium(II)/Pybox Complexes Containing Achiral Phosphonite and Phosphinite
Ligands. Molecules 2020, 25, 990. [CrossRef]
4. Liu, M.; Gui, D.; Deng, P.; Zhou, H. Asymmetric Henry Reaction of 2-Acylpyridine N-Oxides Catalyzed by a
Ni-Aminophenol Sulfonamide Complex: An Unexpected Mononuclear Catalyst. Molecules 2019, 24, 1471.
[CrossRef] [PubMed]
5. Manaprasertsak, A.; Tharamak, S.; Schedl, C.; Roller, A.; Widhalm, M. Improved Access to Chiral
Tetranaphthoazepinium-Based Organocatalysts Using Aqueous Ammonia as Nitrogen Source. Molecules
2019, 24, 3844. [CrossRef] [PubMed]
6. Torregrosa-Chinillach, A.; Sánchez-Laó, A.; Santagostino, E.; Chinchilla, R. Organocatalytic Asymmetric
Conjugate Addition of Aldehydes to Maleimides and Nitroalkenes in Deep Eutectic Solvents. Molecules 2019,
24, 4058. [CrossRef] [PubMed]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
